212 related articles for article (PubMed ID: 35568002)
1. Genomic and transcriptomic somatic alterations of hepatocellular carcinoma in non-cirrhotic livers.
Skidmore ZL; Kunisaki J; Lin Y; Cotto KC; Barnell EK; Hundal J; Krysiak K; Magrini V; Trani L; Walker JR; Fulton R; Brunt EM; Miller CA; Wilson RK; Mardis ER; Griffith M; Chapman W; Griffith OL
Cancer Genet; 2022 Jun; 264-265():90-99. PubMed ID: 35568002
[TBL] [Abstract][Full Text] [Related]
2. Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.
Liu X; Wang SK; Zhang K; Zhang H; Pan Q; Liu Z; Pan H; Xue L; Yen Y; Chu PG
Carcinogenesis; 2015 Feb; 36(2):232-42. PubMed ID: 25542894
[TBL] [Abstract][Full Text] [Related]
3. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy.
Terada T; Terasaki S; Nakanuma Y
Cancer; 1993 Sep; 72(5):1551-6. PubMed ID: 8394196
[TBL] [Abstract][Full Text] [Related]
4. Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma.
Nault JC; Martin Y; Caruso S; Hirsch TZ; Bayard Q; Calderaro J; Charpy C; Copie-Bergman C; Ziol M; Bioulac-Sage P; Couchy G; Blanc JF; Nahon P; Amaddeo G; Ganne-Carrie N; Morcrette G; Chiche L; Duvoux C; Faivre S; Laurent A; Imbeaud S; Rebouissou S; Llovet JM; Seror O; Letouzé E; Zucman-Rossi J
Hepatology; 2020 Jan; 71(1):164-182. PubMed ID: 31206197
[TBL] [Abstract][Full Text] [Related]
5. Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas.
Castven D; Fischer M; Becker D; Heinrich S; Andersen JB; Strand D; Sprinzl MF; Strand S; Czauderna C; Heilmann-Heimbach S; Roessler S; Weinmann A; Wörns MA; Thorgeirsson SS; Galle PR; Matter MS; Lang H; Marquardt JU
Oncotarget; 2017 Jul; 8(30):48688-48700. PubMed ID: 28415775
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma in the non-cirrhotic liver.
Dong Y; Wang WP; Lee WJ; Meloni MF; Clevert DA; Chammas MC; Tannapfel A; Forgione A; Piscaglia F; Dietrich CF
Clin Hemorheol Microcirc; 2022; 80(4):423-436. PubMed ID: 34842182
[TBL] [Abstract][Full Text] [Related]
7. A genomic case study of mixed fibrolamellar hepatocellular carcinoma.
Griffith OL; Griffith M; Krysiak K; Magrini V; Ramu A; Skidmore ZL; Kunisaki J; Austin R; McGrath S; Zhang J; Demeter R; Graves T; Eldred JM; Walker J; Larson DE; Maher CA; Lin Y; Chapman W; Mahadevan A; Miksad R; Nasser I; Hanto DW; Mardis ER
Ann Oncol; 2016 Jun; 27(6):1148-1154. PubMed ID: 27029710
[TBL] [Abstract][Full Text] [Related]
8. Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma.
Ikeda A; Shimizu T; Matsumoto Y; Fujii Y; Eso Y; Inuzuka T; Mizuguchi A; Shimizu K; Hatano E; Uemoto S; Chiba T; Marusawa H
Gastroenterology; 2014 Jan; 146(1):222-32.e35. PubMed ID: 24055508
[TBL] [Abstract][Full Text] [Related]
9. Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma.
Murugesan K; Sharaf R; Montesion M; Moore JA; Pao J; Pavlick DC; Frampton GM; Upadhyay VA; Alexander BM; Miller VA; Javle MM; Bekaii Saab TS; Albacker LA; Ross JS; Ali SM
JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34476330
[TBL] [Abstract][Full Text] [Related]
10. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.
Joseph NM; Tsokos CG; Umetsu SE; Shain AH; Kelley RK; Onodera C; Bowman S; Talevich E; Ferrell LD; Kakar S; Krings G
J Pathol; 2019 Jun; 248(2):164-178. PubMed ID: 30690729
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma: incidental finding in cirrhotic explanted livers.
Caroli-Bottino A; Nascimento CM; Basto S; Ribeiro J; Silveira V; Carvalho AM; Castro PN; Villela-Nogueiro CA; Pannain VL
Transplant Proc; 2005; 37(6):2791-2. PubMed ID: 16182811
[TBL] [Abstract][Full Text] [Related]
12. Cause-specific telomere factors deregulation in hepatocellular carcinoma.
El Idrissi M; Hervieu V; Merle P; Mortreux F; Wattel E
J Exp Clin Cancer Res; 2013 Sep; 32(1):64. PubMed ID: 24020493
[TBL] [Abstract][Full Text] [Related]
13. Liver cell dysplasia in normal, cirrhotic, and hepatocellular carcinoma patients.
Cohen C; Berson SD
Cancer; 1986 Apr; 57(8):1535-8. PubMed ID: 3004693
[TBL] [Abstract][Full Text] [Related]
14. Multiple occurrence of borderline hepatocellular nodules in human cirrhotic livers: possible multicentric origin of hepatocellular carcinoma.
Terada T; Nakanuma Y
Virchows Arch; 1995; 427(4):379-83. PubMed ID: 8548122
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis.
Jee BA; Choi JH; Rhee H; Yoon S; Kwon SM; Nahm JH; Yoo JE; Jeon Y; Choi GH; Woo HG; Park YN
Cancer Res; 2019 Nov; 79(21):5500-5512. PubMed ID: 31506333
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of APOB inactivation in hepatocellular carcinoma.
Lee G; Jeong YS; Kim DW; Kwak MJ; Koh J; Joo EW; Lee JS; Kah S; Sim YE; Yim SY
Exp Mol Med; 2018 Nov; 50(11):1-12. PubMed ID: 30429453
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus.
Takeda H; Takai A; Iguchi E; Mishima M; Arasawa S; Kumagai K; Eso Y; Shimizu T; Takahashi K; Ueda Y; Taura K; Hatano E; Iijima H; Aoyagi H; Aizaki H; Marusawa H; Wakita T; Seno H
Carcinogenesis; 2021 May; 42(5):672-684. PubMed ID: 33617626
[TBL] [Abstract][Full Text] [Related]
18. The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma.
Ahn SM; Haq F; Park I; Nault JC; Zucman-Rossi J; Yu E
BMC Cancer; 2018 May; 18(1):571. PubMed ID: 29776391
[TBL] [Abstract][Full Text] [Related]
19. Liver clear cell foci and viral infection are associated with non-cirrhotic, non-fibrolamellar hepatocellular carcinoma in young patients from South America.
Cano L; Cerapio JP; Ruiz E; Marchio A; Turlin B; Casavilca S; Taxa L; Marti G; Deharo E; Pineau P; Bertani S
Sci Rep; 2018 Jul; 8(1):9945. PubMed ID: 30061721
[TBL] [Abstract][Full Text] [Related]
20. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma.
Aly DM; Gohar NA; Abd El-Hady AA; Khairy M; Abdullatif MM
Asian Pac J Cancer Prev; 2020 Feb; 21(2):555-562. PubMed ID: 32102538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
